Sounding the warning on the potential for oesophageal injury resulting from use of the nMARQ  for ablation of atrial fibrillation

O. Yousuf, H. Calkins
  • EP Europace, January 2015, European Society of Cardiology
  • DOI: 10.1093/europace/euu380
The author haven't finished explaining this publicationThe author haven't finished explaining this publication
Read Publication

http://dx.doi.org/10.1093/europace/euu380

The following have contributed to this page: Dr Hugh Calkins

In partnership with: